Skip to main navigation Skip to search Skip to main content

SWOG S0722: Phase II study of mTOR inhibitor everolimus (RAD001) in advanced Malignant Pleural Mesothelioma (MPM)

  • Sai Hong Ignatius Ou
  • , James Moon
  • , Linda L. Garland
  • , Philip C. Mack
  • , Joseph R. Testa
  • , Anne S. Tsao
  • , Antoniette J. Wozniak
  • , David R. Gandara
  • University of California at Irvine
  • Fred Hutchinson Cancer Research Center
  • University of Arizona
  • University of California at Davis
  • University of Texas Health Science Center at Houston
  • Wayne State University

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'SWOG S0722: Phase II study of mTOR inhibitor everolimus (RAD001) in advanced Malignant Pleural Mesothelioma (MPM)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science